Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy

We previously reported that synthetic vaccine particles (SVP) encapsulating antigens and TLR agonists resulted in augmentation of immune responses with minimal production of systemic inflammatory cytokines. Here we evaluated two different polymer formulations of SVP-encapsulated antigens and tested...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilyinskii, Petr O., Kovalev, Grigoriy I., O’Neil, Conlin P., Roy, Christopher J., Michaud, Alicia M., Drefs, Natalia M., Pechenkin, Mikhail A., Fu, Fen-ni, Johnston, Lloyd P. M., Ovchinnikov, Dmitry A., Kishimoto, Takashi Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983463/
https://www.ncbi.nlm.nih.gov/pubmed/29856772
http://dx.doi.org/10.1371/journal.pone.0197694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983463/
https://www.ncbi.nlm.nih.gov/pubmed/29856772
http://dx.doi.org/10.1371/journal.pone.0197694

Ejemplares similares